Juglans californica pollen

Identification

Name
Juglans californica pollen
Accession Number
DB10397
Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Description

Juglans californica pollen is the pollen of the Juglans californica plant. Juglans californica pollen is mainly used in allergenic testing.

Synonyms
  • California black walnut pollen extract
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Calif. Black Walnut PollenInjection0.05 g/1mLCutaneous; Intradermal; SubcutaneousAllermed Laboratories, Inc.1974-03-12Not applicableUs
California Black WalnutInjection, solution20000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
California Black WalnutInjection, solution40000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
California Black WalnutInjection, solution20000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
California Black WalnutInjection, solution10000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
California Black WalnutInjection, solution0.1 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
California Black WalnutInjection, solution0.05 g/1mLIntradermal; SubcutaneousAntigen Laboratories, Inc.1974-03-23Not applicableUs
California Black WalnutInjection, solution10000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
California Black WalnutInjection, solution0.05 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
California Black WalnutInjection, solution0.05 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Treatment Set TS333001Juglans californica pollen (0.002 g/1mL) + Amaranthus retroflexus pollen (0.002 g/1mL) + Ambrosia artemisiifolia pollen (4000 [AU]/1mL) + Canis lupus familiaris hair (0.002 g/1mL) + Carya tomentosa pollen (0.002 g/1mL) + Celtis occidentalis pollen (0.002 g/1mL) + Felis catus hair (400 [BAU]/1mL) + Phleum pratense pollen (4000 [BAU]/1mL) + Plantago lanceolata pollen (0.002 g/1mL) + Platanus occidentalis pollen (0.002 g/1mL) + Quercus alba pollen (0.002 g/1mL) + Rumex acetosella pollen (0.002 g/1mL) + Salsola kali pollen (0.002 g/1mL) + Urtica dioica pollen (0.002 g/1mL)Injection, solutionIntradermal; SubcutaneousAntigen Laboratories, Inc.1986-10-31Not applicableUs
Walnut MixJuglans californica pollen (0.0167 g/1mL) + Juglans nigra pollen (0.0167 g/1mL) + Juglans regia pollen (0.0167 g/1mL)InjectionPercutaneous; SubcutaneousAllermed Laboratories, Inc.1974-03-12Not applicableUs
Western Walnut Pollen MixJuglans californica pollen (0.025 g/1mL) + Juglans regia pollen (0.025 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUs
Western Walnut Pollen MixJuglans californica pollen (20000 [PNU]/1mL) + Juglans regia pollen (20000 [PNU]/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUs
Western Walnut Pollen MixJuglans californica pollen (10000 [PNU]/1mL) + Juglans regia pollen (10000 [PNU]/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUs
Western Walnut Pollen MixJuglans californica pollen (0.05 g/1mL) + Juglans regia pollen (0.05 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUs
Western Walnut Pollen MixJuglans californica pollen (0.025 g/1mL) + Juglans regia pollen (0.025 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUs
Western Walnut Pollen MixJuglans californica pollen (0.0005 g/1mL) + Juglans regia pollen (0.0005 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUs
Categories
UNII
2147EPR64I
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347910572
RxNav
852561

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
InjectionCutaneous; Intradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.1 g/1mL
Injection, solutionIntradermal; Subcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous20000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous40000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.001 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.05 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.1 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous40000 [PNU]/1mL
Injection, suspensionSubcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous
InjectionPercutaneous; Subcutaneous
SolutionIntradermal; Percutaneous; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on December 01, 2015 13:03 / Updated on March 01, 2020 20:39

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates